Alap: GSFHC
Goldman Sachs Future Health Care Equity ETF (dis) | |
US38149W7700 | |
09.11.2021 | |
Equity | |
Részvény Sectors - Health Care | |
Goldman Sachs | |
Goldman Sachs Asset Management, L.P. | |
USD | |
1 000 | |
5% |
1M | 3M | 6M | 9M | 1R | 3R p.a. | 5R p.a. | 7R p.a. | 10R p.a. | od vnizku p.a. | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Výkonnosť fondu | 0.64% | 2.26% | 9.35% | 10.39% | 3.03% | - | - | - | - | N/A | |
Priemerná výkonnosť (36 meraní) | - | - | - | - | - | ||||||
Volatilita od priemernej výkonnosti | - | - | - | - | - |
Long | Short | Net | |
---|---|---|---|
Részvény | 97.91% | 97.91% | |
Kötvény | |||
Other | |||
Pénz piac | 2.09% | 2.09% |
Aktíva | 250 mil. |
Počet akcíí | 43 |
Počet dlhopisov | 0 |
Priebež. popl. | |
z toho Mng. popl. | 0.75 |
Výk. prémia | |
Trans. popl. |
Dividenda | 0.716 |
Dividendový výnos | 2.06% |
Rozhodný dátum | 26.12.2023 |
Frekvencia výplaty | štvrťročne |
Giant | 32.04% |
Large | 23.35% |
Medium | 38.90% |
Small | 3.12% |
Micro | 0.50% |
P/E | 27.63% |
P/BV | 4.94% |
Healthcare | 97.91% |
Derivatives | 2.09 |
Výnos do splatnosti p.a. | |
Modifikovaná durácia |
United States | 74.71% |
Canada | 0.44% |
Latin America | |
United Kingdom | 7.41% |
Eurozone | 0.63% |
Europe - ex Euro | 9.24% |
Europe - Emerging | |
Africa | |
Middle East | |
Japan | 2.68% |
Australasia | 2.81% |
Asia - Developed | |
Asia - Emerging | |
Emerging Market | |
Developed Country | 97.91% |
Not Classified |
Spoločnosť | Subsektor | Váha | Spoločnosť | Subsektor | Váha |
---|---|---|---|---|---|
Eli Lilly and Co | Healthcare | 10.68% | AstraZeneca PLC | Healthcare | 6.43% |
Novo Nordisk A/S Class B | Healthcare | 6.36% | Boston Scientific Corp | Healthcare | 6.01% |
Intuitive Surgical Inc | Healthcare | 4.63% | Amgen Inc | Healthcare | 4.63% |
AbbVie Inc | Healthcare | 3.93% | Danaher Corp | Healthcare | 3.73% |
The Cooper Companies Inc | Healthcare | 3.38% | Zimmer Biomet Holdings Inc | Healthcare | 3.13% |